Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey
Yıl: 2021 Cilt: 18 Sayı: 1 Sayfa Aralığı: 15 - 22 Metin Dili: İngilizce DOI: 10.4274/tjod.galenos.2021.36418 İndeks Tarihi: 20-06-2021
Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey
Öz: Objective: To determine obstetrician-gynecologists’ (OBGYNs) practice patterns regarding human papillomavirus (HPV) testing in cervical cancer screening.Secondly, we aimed to examine OBGYNs’ adherence to guidelines in the management of women with HPV-positive test results.Materials and Methods: The study was a cross-sectional survey conducted in Antalya and Istanbul provinces in Turkey using a self-reported questionnaire.A 12-item questionnaire form was administered to the participants in face-to-face interviews. Of the targeted participants, 343 OBGYNs completed thequestionnaire.Results: The majority of participants, (81.0%) stated that they offered/used HPV testing in cervical cancer screening. Of those, most OBGYNs (89.9%)preferred to use HPV testing concomitant with cervical cytology (co-testing) whereas only 10.1% preferred to use HPV testing alone (primary HPV testing).The most preferred screening intervals for women with HPV-negative results were 5 years (53.4%) and 3 years (19.9%), respectively. In compliance withthe guidelines, the rate of participants who recommended “referral directly to colposcopy” for women who were HPV16/18-positive and cytology-negative;and “co-testing at 12 months” for women who were positive for HPV genotypes other than HPV16/18 and cytology-negative was 53.1%. Multivariateanalysis revealed that the “professional working setting” was the sole independent determinant of the adherence to the guidelines. OBGYNs working inprivate settings had the worst adherence rate (42.4%).Conclusion: Primary HPV testing is not yet widespread among Turkish OBGYNs. Moreover, adherence to practice guidelines in the management of HPVpositive test results is relatively low. There is a need for continuing medical education regarding screening programs and the management of women withpositive screening results.
Anahtar Kelime: Türkiye’de kadın hastalıkları ve doğum uzmanlarının serviks kanseri taramasında HPV testi ile ilgili uygulama paternleri
Öz: Amaç: Birincil olarak, kadın hastalıkları ve doğum uzmanlarının servikal kanser taramasındaki uygulama paternlerini saptamayı; ikincil olarak ise kadın hastalıkları ve doğum uzmanlarının insan papilloma virüsü (HPV)-pozitif test sonucu olan kadınların yönetiminde kılavuzlara bağlılıklarını incelemeyi amaçladık. Gereç ve Yöntemler: Bu çalışma, bir öz-bildirim anketi kullanılarak, Türkiye’de Antalya ve İstanbul illerinde yapılan çapraz-kesitsel bir araştırmadır. On iki maddelik anket formu, yüz yüze görüşme yöntemi ile katılımcılara uygulandı. Hedeflenen katılımcılardan 343 kadın hastalıkları ve doğum uzmanı anketi tamamladı. Bulgular: Katılımcıların çoğunluğu (%81,0) servikal kanser taramasında HPV testini kullandıklarını/önerdiklerini belirtti. Bu hekimlerin büyük çoğunluğu (%89,9) HPV testini servikal sitoloji ile eş zamanlı (cotest) olarak kullanmayı tercih etmekteyken sadece %10,1’i HPV testini tek başına (primer HPV testi) kullanmayı tercih etmektedir. HPV-negatif sonucu olan kadınlarda en sık tercih edilen tarama aralığı sırasıyla 5 (%53,4) ve 3 yıl (%19,9) idi. Kılavuzlarla uyumlu olarak, HPV 16/18 pozitif ve sitoloji sonucu negatif olan kadınlarda “doğrudan kolposkopi”, HPV16/18 haricindeki HPV genotipleri pozitif iken sitoloji sonucu negatif olan kadınlarda ise “12 ay sonra cotest” öneren katılımcıların oranı %53,1 idi. Çok değişkenli analiz, “profesyonel çalışma ortamı”nın kılavuzlara bağlılığın tek bağımsız belirleyicisi olduğunu gösterdi. Özel kurumlarda çalışan kadın hastalıkları ve doğum uzmanları kılavuzlara en kötü uyum oranına (%42,4) sahipti. Sonuç: Primer HPV testi kullanımı Türk kadın hastalıkları ve doğum uzmanları arasında henüz yaygınlaşmamıştır. Üstelik, HPV-pozitif test sonuçlarının yönetiminde uygulama kılavuzlarına bağlılık görece düşüktür. Tarama programları ve pozitif tarama sonuçları olan kadınların yönetimi ile ilgili sürekli tıp eğitimine ihtiyaç bulunmaktadır.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. International Agency for Research on Cancer and World Health Organization. Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 26 February 2020.
- 2. Kjær SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010;102:1478-88.
- 3. Turkish Ministry of Health. Cancer Statistics in Turkey. https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/istatistik/Turkiye_Kanser_Istatistikleri_2015.pdf. Accessed 26 February 2020.
- 4. Gultekin M, Zayifoglu Karaca M, Kucukyildiz I, Dundar S, Boztas G, Semra Turan H, et al. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women. Int J Cancer 2018;142:1952-8.
- 5. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-44.
- 6. Castanon A, Landy R, Sasieni PD. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix? Int J Cancer 2016;139:1040-5.
- 7. Gilani SM, Mazzara PF. Cytohistologic correlation in premenopausal and postmenopausal women. Acta Cytol 2013;57:575-80.
- 8. Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev 2017;8:008587.
- 9. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.
- 10. Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the firstline screening test. Gynecol Oncol 2015;136:189-97. 11. Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, et al. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst 2014;106:dju153.
- 12. Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol 2015;136:178-82.
- 13. Practice Bulletin No. 157: Cervical Cancer Screening and Prevention. Obstet Gynecol 2016;127:1-20.
- 14. NHS Cervical Screening Programme Colposcopy and Programme Management. NHSCSP Publication number 20. Third Edition March 2016. https://www.bsccp.org.uk/assets/file/uploads/resources/NHSCSP_20_Colposcopy_and_Programme_Management_(3rd_Edition)_(2).pdf. Accessed 26 February 2020
- 15. Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, et al. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Glob Oncol 2016;3:635-57.
- 16. Demirgöz M, Şahiner N. The Effect of Health Belief Model Based Training on Cervical Cancer Screening Behaviors 2020;10:223-7.
- 17. Survey Random Sample Calculator. https://www.custominsight.com/articles/random-sample-calculator.asp. Accessed 26 February 2020.
- 18. Turkish Ministry of Health Report on Health Education and Health Manpower in Turkey. https://www.saglik.gov.tr/TR,11659/saglikbakanligi-turkiyede-saglik-egitimi-ve-saglik-insangucu-durumraporu-2014.html
- 19. Darwish-Yassine M, Garvin AD, Johnston CM, Zoschnick L, Conners A, Laing S, et al. An assessment of gynecological cytology screening practices among health care providers nationwide. Arch Pathol Lab Med 2015;139:650-5.
- 20. Cooper CP, Saraiya M. Primary HPV testing recommendations of US providers, 2015. Prev Med 2017;105:372-7.
- 21. Caglioti C, Pileggi C, Nobile CG, Pavia M. Gynecologists and human papillomavirus DNA testing: exploring knowledge, attitudes, and practice in Italy. Eur J Cancer Prev 2017;26:249-56.
| APA | Akgün Aktaş B, Toptas T, ÜREYEN I, doğan s, Uysal A (2021). Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. , 15 - 22. 10.4274/tjod.galenos.2021.36418 |
| Chicago | Akgün Aktaş Betül,Toptas Tayfun,ÜREYEN Isin,doğan selen,Uysal Aysel Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. (2021): 15 - 22. 10.4274/tjod.galenos.2021.36418 |
| MLA | Akgün Aktaş Betül,Toptas Tayfun,ÜREYEN Isin,doğan selen,Uysal Aysel Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. , 2021, ss.15 - 22. 10.4274/tjod.galenos.2021.36418 |
| AMA | Akgün Aktaş B,Toptas T,ÜREYEN I,doğan s,Uysal A Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. . 2021; 15 - 22. 10.4274/tjod.galenos.2021.36418 |
| Vancouver | Akgün Aktaş B,Toptas T,ÜREYEN I,doğan s,Uysal A Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. . 2021; 15 - 22. 10.4274/tjod.galenos.2021.36418 |
| IEEE | Akgün Aktaş B,Toptas T,ÜREYEN I,doğan s,Uysal A "Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey." , ss.15 - 22, 2021. 10.4274/tjod.galenos.2021.36418 |
| ISNAD | Akgün Aktaş, Betül vd. "Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey". (2021), 15-22. https://doi.org/10.4274/tjod.galenos.2021.36418 |
| APA | Akgün Aktaş B, Toptas T, ÜREYEN I, doğan s, Uysal A (2021). Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. Turkish Journal of Obstetrics and Gynecology, 18(1), 15 - 22. 10.4274/tjod.galenos.2021.36418 |
| Chicago | Akgün Aktaş Betül,Toptas Tayfun,ÜREYEN Isin,doğan selen,Uysal Aysel Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. Turkish Journal of Obstetrics and Gynecology 18, no.1 (2021): 15 - 22. 10.4274/tjod.galenos.2021.36418 |
| MLA | Akgün Aktaş Betül,Toptas Tayfun,ÜREYEN Isin,doğan selen,Uysal Aysel Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. Turkish Journal of Obstetrics and Gynecology, vol.18, no.1, 2021, ss.15 - 22. 10.4274/tjod.galenos.2021.36418 |
| AMA | Akgün Aktaş B,Toptas T,ÜREYEN I,doğan s,Uysal A Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. Turkish Journal of Obstetrics and Gynecology. 2021; 18(1): 15 - 22. 10.4274/tjod.galenos.2021.36418 |
| Vancouver | Akgün Aktaş B,Toptas T,ÜREYEN I,doğan s,Uysal A Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. Turkish Journal of Obstetrics and Gynecology. 2021; 18(1): 15 - 22. 10.4274/tjod.galenos.2021.36418 |
| IEEE | Akgün Aktaş B,Toptas T,ÜREYEN I,doğan s,Uysal A "Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey." Turkish Journal of Obstetrics and Gynecology, 18, ss.15 - 22, 2021. 10.4274/tjod.galenos.2021.36418 |
| ISNAD | Akgün Aktaş, Betül vd. "Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey". Turkish Journal of Obstetrics and Gynecology 18/1 (2021), 15-22. https://doi.org/10.4274/tjod.galenos.2021.36418 |
